Reports

Industry Research Reports

Global In Vivo Imaging Systems Market Outlook, In‑Depth Analysis & Forecast to 2031

Global In Vivo Imaging Systems Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-07-31

Pages: 184 Pages

Report ld: 4808012

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

In Vivo Imaging Systems Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

3.1%

marketSize

Market Size,2031

USD 169

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 141 million
Market Forecast in 2031(Value)
US$ 169 million
CAGR
3.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global In Vivo Imaging Systems market is projected to grow from US$ 137 million in 2024 to US$ 169 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

Small animal in vivo imaging technology is a non-invasive method widely used in biomedical research, which can observe and track biological processes in small animals in real time. Through this technology, researchers can gain a deep understanding of dynamic changes such as disease progression, drug response and gene expression. Common in vivo imaging technologies include optical imaging, magnetic resonance imaging (MRI), positron emission tomography (PET), etc. This technology helps to reduce the use of experimental animals, provide more efficient and accurate experimental data, and promote the development of new drugs and the study of disease mechanisms. The main manufacturers of small animal in vivo imaging systems (In Vivo Imaging Systems) in the world include Perkin Elmer, Canon Medical Systems, Bruker, Idexx Laboratories and Hallmarq Veterinary Imaging, etc. The top five manufacturers account for about 47% of the global market share. In terms of revenue, North America is the largest market, accounting for about 64% of the market share. In terms of product type, optical imaging is the largest segment, accounting for about 65% of the revenue share, and in terms of downstream, laboratories are the largest downstream field, accounting for 78% of the revenue share. In the small animal in vivo imaging industry, manufacturers need to take multiple measures to promote technological innovation and enhance market competitiveness. First, manufacturers should focus on technology research and development, and continuously improve the resolution, sensitivity and multimodal functions of imaging equipment so that they can more accurately capture biological processes in small animals. In addition, manufacturers should focus on developing user-friendly software platforms to ensure the automation and simplicity of data acquisition and analysis to reduce the operational burden of researchers and improve experimental efficiency. Secondly, manufacturers should strengthen cooperation with scientific research institutions and pharmaceutical companies to meet the needs of different industries and fields through customized solutions. For example, in cutting-edge fields such as cancer research, new drug development and gene therapy, providing targeted imaging equipment and services can effectively expand the market. At the same time, manufacturers should also pay attention to the cost-effectiveness of equipment, while maintaining high-quality imaging performance, by optimizing production processes and supply chains, reducing the manufacturing cost of equipment, making in vivo imaging technology more economically feasible, and attracting more small and medium-sized laboratories to use it. In addition, with the increasing global attention to animal welfare, manufacturers also need to ensure that their equipment complies with ethical standards and regulations, reduce unnecessary harm to experimental animals, and provide more accurate non-invasive imaging technology to help researchers achieve more humane experimental design. Finally, manufacturers should establish a comprehensive after-sales service system to provide equipment maintenance, technical support and operation training to ensure that users can use the equipment in a long-term and stable manner. Through a comprehensive layout in technology, cooperation, cost, ethics and service, manufacturers can maintain a sustained competitive advantage in the small animal in vivo imaging industry, meet the growing needs of scientific researchers and pharmaceutical companies, and promote the advancement of biomedical research.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global In Vivo Imaging Systems market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Perkin Elmer
  • Canon Medical Systems
  • Bruker
  • Idexx Laboratories
  • Hallmarq Veterinary Imaging
  • Huantong Nuclear Magnet
  • Sunny Optical
  • Photon
  • MILABS
  • iThera Medical
  • Vieworks
  • Aspect Imaging
  • TOMOWAVE
  • Trifoil Imaging
  • Clinx
  • Raylight
  • Spectral Instruments Imaging
  • Novel Medical
  • Tanon
  • Biolight
  • PINGSENG Healthcare
  • Fujifilm Visualsonics

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Optical Imaging
  • MRI
  • Ultrasound
  • Others

Segment by Application

  • Laboratory
  • Pet Hospital and Clinic

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the In Vivo Imaging Systems study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.

marn_i1

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to In Vivo Imaging Systems: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global In Vivo Imaging Systems Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Optical Imaging

1.2.3 MRI

1.2.4 Ultrasound

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global In Vivo Imaging Systems Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Laboratory

1.3.3 Pet Hospital and Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global In Vivo Imaging Systems Revenue Estimates and Forecasts 2020-2031

2.2 Global In Vivo Imaging Systems Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global In Vivo Imaging Systems Sales Estimates and Forecasts 2020-2031

2.4 Global In Vivo Imaging Systems Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Competition by Manufacturers

3.1 Global In Vivo Imaging Systems Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global In Vivo Imaging Systems Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Optical Imaging Market Size by Manufacturers

3.5.2 MRI Market Size by Manufacturers

3.5.3 Ultrasound Market Size by Manufacturers

3.5.4 Others Market Size by Manufacturers

3.6 Global In Vivo Imaging Systems Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

4 Global Product Segmentation Analysis

4.1 Global In Vivo Imaging Systems Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global In Vivo Imaging Systems Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

muLu

5 Global Downstream Application Analysis

5.1 Global In Vivo Imaging Systems Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global In Vivo Imaging Systems Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

muLu

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)

6.4 North America In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America In Vivo Imaging Systems Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

muLu

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)

7.4 Europe In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe In Vivo Imaging Systems Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific In Vivo Imaging Systems Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

muLu

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)

9.4 Central and South America In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America In Vivo Imaging Systems Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa In Vivo Imaging Systems Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

muLu

11 Corporate Profile

11.1 Perkin Elmer

11.1.1 Perkin Elmer Corporation Information

11.1.2 Perkin Elmer Business Overview

11.1.3 Perkin Elmer In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.1.4 Perkin Elmer In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Perkin Elmer In Vivo Imaging Systems Sales by Product in 2024

11.1.6 Perkin Elmer In Vivo Imaging Systems Sales by Application in 2024

11.1.7 Perkin Elmer In Vivo Imaging Systems Sales by Geographic Area in 2024

11.1.8 Perkin Elmer In Vivo Imaging Systems SWOT Analysis

11.1.9 Perkin Elmer Recent Developments

11.2 Canon Medical Systems

11.2.1 Canon Medical Systems Corporation Information

11.2.2 Canon Medical Systems Business Overview

11.2.3 Canon Medical Systems In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.2.4 Canon Medical Systems In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Canon Medical Systems In Vivo Imaging Systems Sales by Product in 2024

11.2.6 Canon Medical Systems In Vivo Imaging Systems Sales by Application in 2024

11.2.7 Canon Medical Systems In Vivo Imaging Systems Sales by Geographic Area in 2024

11.2.8 Canon Medical Systems In Vivo Imaging Systems SWOT Analysis

11.2.9 Canon Medical Systems Recent Developments

11.3 Bruker

11.3.1 Bruker Corporation Information

11.3.2 Bruker Business Overview

11.3.3 Bruker In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.3.4 Bruker In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Bruker In Vivo Imaging Systems Sales by Product in 2024

11.3.6 Bruker In Vivo Imaging Systems Sales by Application in 2024

11.3.7 Bruker In Vivo Imaging Systems Sales by Geographic Area in 2024

11.3.8 Bruker In Vivo Imaging Systems SWOT Analysis

11.3.9 Bruker Recent Developments

11.4 Idexx Laboratories

11.4.1 Idexx Laboratories Corporation Information

11.4.2 Idexx Laboratories Business Overview

11.4.3 Idexx Laboratories In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.4.4 Idexx Laboratories In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Idexx Laboratories In Vivo Imaging Systems Sales by Product in 2024

11.4.6 Idexx Laboratories In Vivo Imaging Systems Sales by Application in 2024

11.4.7 Idexx Laboratories In Vivo Imaging Systems Sales by Geographic Area in 2024

11.4.8 Idexx Laboratories In Vivo Imaging Systems SWOT Analysis

11.4.9 Idexx Laboratories Recent Developments

11.5 Hallmarq Veterinary Imaging

11.5.1 Hallmarq Veterinary Imaging Corporation Information

11.5.2 Hallmarq Veterinary Imaging Business Overview

11.5.3 Hallmarq Veterinary Imaging In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.5.4 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales by Product in 2024

11.5.6 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales by Application in 2024

11.5.7 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales by Geographic Area in 2024

11.5.8 Hallmarq Veterinary Imaging In Vivo Imaging Systems SWOT Analysis

11.5.9 Hallmarq Veterinary Imaging Recent Developments

11.6 Huantong Nuclear Magnet

11.6.1 Huantong Nuclear Magnet Corporation Information

11.6.2 Huantong Nuclear Magnet Business Overview

11.6.3 Huantong Nuclear Magnet In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.6.4 Huantong Nuclear Magnet In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Huantong Nuclear Magnet Recent Developments

11.7 Sunny Optical

11.7.1 Sunny Optical Corporation Information

11.7.2 Sunny Optical Business Overview

11.7.3 Sunny Optical In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.7.4 Sunny Optical In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Sunny Optical Recent Developments

11.8 Photon

11.8.1 Photon Corporation Information

11.8.2 Photon Business Overview

11.8.3 Photon In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.8.4 Photon In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Photon Recent Developments

11.9 MILABS

11.9.1 MILABS Corporation Information

11.9.2 MILABS Business Overview

11.9.3 MILABS In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.9.4 MILABS In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 MILABS Recent Developments

11.10 iThera Medical

11.10.1 iThera Medical Corporation Information

11.10.2 iThera Medical Business Overview

11.10.3 iThera Medical In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.10.4 iThera Medical In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 iThera Medical Recent Developments

11.11 Vieworks

11.11.1 Vieworks Corporation Information

11.11.2 Vieworks Business Overview

11.11.3 Vieworks In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.11.4 Vieworks In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Vieworks Recent Developments

11.12 Aspect Imaging

11.12.1 Aspect Imaging Corporation Information

11.12.2 Aspect Imaging Business Overview

11.12.3 Aspect Imaging In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.12.4 Aspect Imaging In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Aspect Imaging Recent Developments

11.13 TOMOWAVE

11.13.1 TOMOWAVE Corporation Information

11.13.2 TOMOWAVE Business Overview

11.13.3 TOMOWAVE In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.13.4 TOMOWAVE In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 TOMOWAVE Recent Developments

11.14 Trifoil Imaging

11.14.1 Trifoil Imaging Corporation Information

11.14.2 Trifoil Imaging Business Overview

11.14.3 Trifoil Imaging In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.14.4 Trifoil Imaging In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 Trifoil Imaging Recent Developments

11.15 Clinx

11.15.1 Clinx Corporation Information

11.15.2 Clinx Business Overview

11.15.3 Clinx In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.15.4 Clinx In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 Clinx Recent Developments

11.16 Raylight

11.16.1 Raylight Corporation Information

11.16.2 Raylight Business Overview

11.16.3 Raylight In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.16.4 Raylight In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.16.5 Raylight Recent Developments

11.17 Spectral Instruments Imaging

11.17.1 Spectral Instruments Imaging Corporation Information

11.17.2 Spectral Instruments Imaging Business Overview

11.17.3 Spectral Instruments Imaging In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.17.4 Spectral Instruments Imaging In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.17.5 Spectral Instruments Imaging Recent Developments

11.18 Novel Medical

11.18.1 Novel Medical Corporation Information

11.18.2 Novel Medical Business Overview

11.18.3 Novel Medical In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.18.4 Novel Medical In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.18.5 Novel Medical Recent Developments

11.19 Tanon

11.19.1 Tanon Corporation Information

11.19.2 Tanon Business Overview

11.19.3 Tanon In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.19.4 Tanon In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.19.5 Tanon Recent Developments

11.20 Biolight

11.20.1 Biolight Corporation Information

11.20.2 Biolight Business Overview

11.20.3 Biolight In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.20.4 Biolight In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.20.5 Biolight Recent Developments

11.21 PINGSENG Healthcare

11.21.1 PINGSENG Healthcare Corporation Information

11.21.2 PINGSENG Healthcare Business Overview

11.21.3 PINGSENG Healthcare In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.21.4 PINGSENG Healthcare In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.21.5 PINGSENG Healthcare Recent Developments

11.22 Fujifilm Visualsonics

11.22.1 Fujifilm Visualsonics Corporation Information

11.22.2 Fujifilm Visualsonics Business Overview

11.22.3 Fujifilm Visualsonics In Vivo Imaging Systems Product Models, Descriptions and Specifications

11.22.4 Fujifilm Visualsonics In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)

11.22.5 Fujifilm Visualsonics Recent Developments

muLu

12 Value Chain and Supply-Chain Analysis

12.1 In Vivo Imaging Systems Industry Chain

12.2 In Vivo Imaging Systems Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 In Vivo Imaging Systems Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 In Vivo Imaging Systems Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 In Vivo Imaging Systems Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

muLu

14 Key Findings in the Global In Vivo Imaging Systems Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global In Vivo Imaging Systems Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global In Vivo Imaging Systems Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global In Vivo Imaging Systems Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global In Vivo Imaging Systems Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global In Vivo Imaging Systems Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global In Vivo Imaging Systems Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global In Vivo Imaging Systems Sales by Region (2020-2025) & (Units)
Table 8. Global In Vivo Imaging Systems Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global In Vivo Imaging Systems Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global In Vivo Imaging Systems Sales Share by Manufacturers (2020-2025)
Table 12. Global In Vivo Imaging Systems Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global In Vivo Imaging Systems Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global In Vivo Imaging Systems by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Imaging Systems as of 2024)
Table 16. Global In Vivo Imaging Systems Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global In Vivo Imaging Systems Average Selling Price (ASP) by Manufacturers (2020-2025) & (K USD/Unit)
Table 18. Key Manufacturers In Vivo Imaging Systems Manufacturing Base and Headquarters
Table 19. Global In Vivo Imaging Systems Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global In Vivo Imaging Systems Sales by Type (2020-2025) & (Units)
Table 23. Global In Vivo Imaging Systems Sales by Type (2026-2031) & (Units)
Table 24. Global In Vivo Imaging Systems Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global In Vivo Imaging Systems Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global In Vivo Imaging Systems ASP by Type (2020-2031) & (K USD/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global In Vivo Imaging Systems Sales by Application (2020-2025) & (Units)
Table 29. Global In Vivo Imaging Systems Sales by Application (2026-2031) & (Units)
Table 30. In Vivo Imaging Systems High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global In Vivo Imaging Systems Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global In Vivo Imaging Systems Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global In Vivo Imaging Systems ASP by Application (2020-2031) & (K USD/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America In Vivo Imaging Systems Growth Accelerators and Market Barriers
Table 37. North America In Vivo Imaging Systems Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America In Vivo Imaging Systems Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe In Vivo Imaging Systems Growth Accelerators and Market Barriers
Table 40. Europe In Vivo Imaging Systems Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe In Vivo Imaging Systems Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific In Vivo Imaging Systems Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific In Vivo Imaging Systems Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific In Vivo Imaging Systems Growth Accelerators and Market Barriers
Table 45. Southeast Asia In Vivo Imaging Systems Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America In Vivo Imaging Systems Investment Opportunities and Key Challenges
Table 47. Central and South America In Vivo Imaging Systems Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa In Vivo Imaging Systems Investment Opportunities and Key Challenges
Table 49. Middle East and Africa In Vivo Imaging Systems Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Perkin Elmer Corporation Information
Table 51. Perkin Elmer Description and Major Businesses
Table 52. Perkin Elmer Product Models, Descriptions and Specifications
Table 53. Perkin Elmer Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 54. Perkin Elmer Sales Value Proportion by Product in 2024
Table 55. Perkin Elmer Sales Value Proportion by Application in 2024
Table 56. Perkin Elmer Sales Value Proportion by Geographic Area in 2024
Table 57. Perkin Elmer In Vivo Imaging Systems SWOT Analysis
Table 58. Perkin Elmer Recent Developments
Table 59. Canon Medical Systems Corporation Information
Table 60. Canon Medical Systems Description and Major Businesses
Table 61. Canon Medical Systems Product Models, Descriptions and Specifications
Table 62. Canon Medical Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 63. Canon Medical Systems Sales Value Proportion by Product in 2024
Table 64. Canon Medical Systems Sales Value Proportion by Application in 2024
Table 65. Canon Medical Systems Sales Value Proportion by Geographic Area in 2024
Table 66. Canon Medical Systems In Vivo Imaging Systems SWOT Analysis
Table 67. Canon Medical Systems Recent Developments
Table 68. Bruker Corporation Information
Table 69. Bruker Description and Major Businesses
Table 70. Bruker Product Models, Descriptions and Specifications
Table 71. Bruker Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 72. Bruker Sales Value Proportion by Product in 2024
Table 73. Bruker Sales Value Proportion by Application in 2024
Table 74. Bruker Sales Value Proportion by Geographic Area in 2024
Table 75. Bruker In Vivo Imaging Systems SWOT Analysis
Table 76. Bruker Recent Developments
Table 77. Idexx Laboratories Corporation Information
Table 78. Idexx Laboratories Description and Major Businesses
Table 79. Idexx Laboratories Product Models, Descriptions and Specifications
Table 80. Idexx Laboratories Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 81. Idexx Laboratories Sales Value Proportion by Product in 2024
Table 82. Idexx Laboratories Sales Value Proportion by Application in 2024
Table 83. Idexx Laboratories Sales Value Proportion by Geographic Area in 2024
Table 84. Idexx Laboratories In Vivo Imaging Systems SWOT Analysis
Table 85. Idexx Laboratories Recent Developments
Table 86. Hallmarq Veterinary Imaging Corporation Information
Table 87. Hallmarq Veterinary Imaging Description and Major Businesses
Table 88. Hallmarq Veterinary Imaging Product Models, Descriptions and Specifications
Table 89. Hallmarq Veterinary Imaging Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 90. Hallmarq Veterinary Imaging Sales Value Proportion by Product in 2024
Table 91. Hallmarq Veterinary Imaging Sales Value Proportion by Application in 2024
Table 92. Hallmarq Veterinary Imaging Sales Value Proportion by Geographic Area in 2024
Table 93. Hallmarq Veterinary Imaging In Vivo Imaging Systems SWOT Analysis
Table 94. Hallmarq Veterinary Imaging Recent Developments
Table 95. Huantong Nuclear Magnet Corporation Information
Table 96. Huantong Nuclear Magnet Description and Major Businesses
Table 97. Huantong Nuclear Magnet Product Models, Descriptions and Specifications
Table 98. Huantong Nuclear Magnet Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 99. Huantong Nuclear Magnet Recent Developments
Table 100. Sunny Optical Corporation Information
Table 101. Sunny Optical Description and Major Businesses
Table 102. Sunny Optical Product Models, Descriptions and Specifications
Table 103. Sunny Optical Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 104. Sunny Optical Recent Developments
Table 105. Photon Corporation Information
Table 106. Photon Description and Major Businesses
Table 107. Photon Product Models, Descriptions and Specifications
Table 108. Photon Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 109. Photon Recent Developments
Table 110. MILABS Corporation Information
Table 111. MILABS Description and Major Businesses
Table 112. MILABS Product Models, Descriptions and Specifications
Table 113. MILABS Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 114. MILABS Recent Developments
Table 115. iThera Medical Corporation Information
Table 116. iThera Medical Description and Major Businesses
Table 117. iThera Medical Product Models, Descriptions and Specifications
Table 118. iThera Medical Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 119. iThera Medical Recent Developments
Table 120. Vieworks Corporation Information
Table 121. Vieworks Description and Major Businesses
Table 122. Vieworks Product Models, Descriptions and Specifications
Table 123. Vieworks Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 124. Vieworks Recent Developments
Table 125. Aspect Imaging Corporation Information
Table 126. Aspect Imaging Description and Major Businesses
Table 127. Aspect Imaging Product Models, Descriptions and Specifications
Table 128. Aspect Imaging Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 129. Aspect Imaging Recent Developments
Table 130. TOMOWAVE Corporation Information
Table 131. TOMOWAVE Description and Major Businesses
Table 132. TOMOWAVE Product Models, Descriptions and Specifications
Table 133. TOMOWAVE Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 134. TOMOWAVE Recent Developments
Table 135. Trifoil Imaging Corporation Information
Table 136. Trifoil Imaging Description and Major Businesses
Table 137. Trifoil Imaging Product Models, Descriptions and Specifications
Table 138. Trifoil Imaging Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 139. Trifoil Imaging Recent Developments
Table 140. Clinx Corporation Information
Table 141. Clinx Description and Major Businesses
Table 142. Clinx Product Models, Descriptions and Specifications
Table 143. Clinx Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 144. Clinx Recent Developments
Table 145. Raylight Corporation Information
Table 146. Raylight Description and Major Businesses
Table 147. Raylight Product Models, Descriptions and Specifications
Table 148. Raylight Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 149. Raylight Recent Developments
Table 150. Spectral Instruments Imaging Corporation Information
Table 151. Spectral Instruments Imaging Description and Major Businesses
Table 152. Spectral Instruments Imaging Product Models, Descriptions and Specifications
Table 153. Spectral Instruments Imaging Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 154. Spectral Instruments Imaging Recent Developments
Table 155. Novel Medical Corporation Information
Table 156. Novel Medical Description and Major Businesses
Table 157. Novel Medical Product Models, Descriptions and Specifications
Table 158. Novel Medical Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 159. Novel Medical Recent Developments
Table 160. Tanon Corporation Information
Table 161. Tanon Description and Major Businesses
Table 162. Tanon Product Models, Descriptions and Specifications
Table 163. Tanon Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 164. Tanon Recent Developments
Table 165. Biolight Corporation Information
Table 166. Biolight Description and Major Businesses
Table 167. Biolight Product Models, Descriptions and Specifications
Table 168. Biolight Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 169. Biolight Recent Developments
Table 170. PINGSENG Healthcare Corporation Information
Table 171. PINGSENG Healthcare Description and Major Businesses
Table 172. PINGSENG Healthcare Product Models, Descriptions and Specifications
Table 173. PINGSENG Healthcare Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 174. PINGSENG Healthcare Recent Developments
Table 175. Fujifilm Visualsonics Corporation Information
Table 176. Fujifilm Visualsonics Description and Major Businesses
Table 177. Fujifilm Visualsonics Product Models, Descriptions and Specifications
Table 178. Fujifilm Visualsonics Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 179. Fujifilm Visualsonics Recent Developments
Table 180. Key Raw Materials Distribution
Table 181. Raw Materials Key Suppliers
Table 182. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 183. Milestones in Production Technology Evolution
Table 184. Distributors List
Table 185. Market Trends and Market Evolution
Table 186. Market Drivers and Opportunities
Table 187. Market Challenges, Risks, and Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. In Vivo Imaging Systems Product Picture
Figure 2. Global In Vivo Imaging Systems Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Optical Imaging Product Picture
Figure 4. MRI Product Picture
Figure 5. Ultrasound Product Picture
Figure 6. Others Product Picture
Figure 7. Global In Vivo Imaging Systems Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Laboratory
Figure 9. Pet Hospital and Clinic
Figure 10. In Vivo Imaging Systems Report Years Considered
Figure 11. Global In Vivo Imaging Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 13. Global In Vivo Imaging Systems Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global In Vivo Imaging Systems Revenue Market Share by Region (2020-2031)
Figure 15. Global In Vivo Imaging Systems Sales (2020-2031) & (Units)
Figure 16. Global In Vivo Imaging Systems Sales (CAGR) by Region (2020-2031) (Units)
Figure 17. Global In Vivo Imaging Systems Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers In Vivo Imaging Systems Sales Volume Market Share in 2024
Figure 19. Global In Vivo Imaging Systems Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Optical Imaging Revenue Market Share by Manufacturer in 2024
Figure 22. MRI Revenue Market Share by Manufacturer in 2024
Figure 23. Ultrasound Revenue Market Share by Manufacturer in 2024
Figure 24. Others Revenue Market Share by Manufacturer in 2024
Figure 25. Global In Vivo Imaging Systems Sales Market Share by Type (2020-2031)
Figure 26. Global In Vivo Imaging Systems Revenue Market Share by Type (2020-2031)
Figure 27. Global In Vivo Imaging Systems Sales Market Share by Application (2020-2031)
Figure 28. Global In Vivo Imaging Systems Revenue Market Share by Application (2020-2031)
Figure 29. North America In Vivo Imaging Systems Sales YoY (2020-2031) & (Units)
Figure 30. North America In Vivo Imaging Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers In Vivo Imaging Systems Sales Revenue (US$ Million) in 2024
Figure 32. North America In Vivo Imaging Systems Sales Volume (Units) by Type (2020- 2031)
Figure 33. North America In Vivo Imaging Systems Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America In Vivo Imaging Systems Sales Volume (Units) by Application (2020-2031)
Figure 35. North America In Vivo Imaging Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 37. Canada In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 39. Europe In Vivo Imaging Systems Sales YoY (2020-2031) & (Units)
Figure 40. Europe In Vivo Imaging Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers In Vivo Imaging Systems Sales Revenue (US$ Million) in 2024
Figure 42. Europe In Vivo Imaging Systems Sales Volume (Units) by Type (2020-2031)
Figure 43. Europe In Vivo Imaging Systems Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe In Vivo Imaging Systems Sales Volume (Units) by Application (2020-2031)
Figure 45. Europe In Vivo Imaging Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 47. France In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 49. Italy In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 50. Russia In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific In Vivo Imaging Systems Sales YoY (2020-2031) & (Units)
Figure 52. Asia-Pacific In Vivo Imaging Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers In Vivo Imaging Systems Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific In Vivo Imaging Systems Sales Volume (Units) by Type (2020- 2031)
Figure 55. Asia-Pacific In Vivo Imaging Systems Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific In Vivo Imaging Systems Sales Volume (Units) by Application (2020-2031)
Figure 57. Asia-Pacific In Vivo Imaging Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 59. Japan In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 62. India In Vivo Imaging Systems Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America In Vivo Imaging Systems Sales YoY (2020-2031) & (Units)
Figure 64. Central and South America In Vivo Imaging Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers In Vivo Imaging Systems Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America In Vivo Imaging Systems Sales Volume (Units) by Type (2021-2031)
Figure 67. Central and South America In Vivo Imaging Systems Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America In Vivo Imaging Systems Sales Volume (Units) by Application (2020-2031)
Figure 69. Central and South America In Vivo Imaging Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil In Vivo Imaging Systems Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina In Vivo Imaging Systems Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa In Vivo Imaging Systems Sales YoY (2020-2031) & (Units)
Figure 73. Middle East and Africa In Vivo Imaging Systems Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers In Vivo Imaging Systems Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa In Vivo Imaging Systems Sales Volume (Units) by Type (2021-2031)
Figure 76. South America In Vivo Imaging Systems Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa In Vivo Imaging Systems Sales Volume (Units) by Application (2020-2031)
Figure 78. Middle East and Africa In Vivo Imaging Systems Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries In Vivo Imaging Systems Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey In Vivo Imaging Systems Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt In Vivo Imaging Systems Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa In Vivo Imaging Systems Revenue (2020-2025) & (US$ Million)
Figure 83. In Vivo Imaging Systems Industry Chain Mapping
Figure 84. Regional In Vivo Imaging Systems Manufacturing Base Distribution (%)
Figure 85. Global In Vivo Imaging Systems Production Market Share by Region (2020-2031)
Figure 86. In Vivo Imaging Systems Production Process
Figure 87. Regional In Vivo Imaging Systems Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global In Vivo Imaging Systems market?zhanKai
The top companies in the global In Vivo Imaging Systems market are Perkin Elmer、Canon Medical Systems、Bruker.
Which region is expected to have the highest market share?shouQi
What was the global market size of In Vivo Imaging Systems in 2031?shouQi
What was the global market size of In Vivo Imaging Systems in 2025?shouQi
What is the annual compound growth rate of the global In Vivo Imaging Systems market size from 2025 to 2031?shouQi
den_biaoTiZhungShi

Related Reports

  • Global In Vivo Imaging Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

    Global In Vivo Imaging Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

    The global In Vivo Imaging Systems market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 174 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.

    selected

    Published Date: 2026-01-05

    page

    Pages: 119

    USD 4250.00

    (Single User License)

  • Global In Vivo Imaging Systems Market Research Report 2026

    Global In Vivo Imaging Systems Market Research Report 2026

    The global In Vivo Imaging Systems market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 3.1% from 2026 to 2032.

    selected

    Published Date: 2026-01-05

    page

    Pages: 146

    USD 2900.00

    (Single User License)

  • In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

    In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

    The global market for In Vivo Imaging Systems was estimated to be worth US$ 141 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 3.1% from 2026 to 2032.

    selected

    Published Date: 2026-01-05

    page

    Pages: 165

    USD 3950.00

    (Single User License)

  • Global In Vivo Imaging Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

    Global In Vivo Imaging Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

    The global In Vivo Imaging Systems market size was US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.

    selected

    Published Date: 2025-09-10

    page

    Pages: 116

    USD 4250.00

    (Single User License)

  • In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

    In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

    The global market for In Vivo Imaging Systems was estimated to be worth US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.

    selected

    Published Date: 2025-01-19

    page

    Pages: 157

    USD 3950.00

    (Single User License)

  • Global In Vivo Imaging Systems Market Research Report 2025

    Global In Vivo Imaging Systems Market Research Report 2025

    The global market for In Vivo Imaging Systems was valued at US$ 137 million in the year 2024 and is projected to reach a revised size of US$ 169 million by 2031, growing at a CAGR of 3.1% during the forecast period.

    selected

    Published Date: 2025-01-19

    page

    Pages: 111

    USD 2900.00

    (Single User License)

  • Global and United States In Vivo Imaging Systems Market Report & Forecast 2024-2030

    Global and United States In Vivo Imaging Systems Market Report & Forecast 2024-2030

    Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

    selected

    Published Date: 2024-09-08

    page

    Pages: 174

    USD 4350.00

    (Single User License)

  • In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

    In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

    Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

    selected

    Published Date: 2024-09-08

    page

    Pages: 160

    USD 3950.00

    (Single User License)

  • Global In Vivo Imaging Systems Market Insights, Forecast to 2030

    Global In Vivo Imaging Systems Market Insights, Forecast to 2030

    Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

    selected

    Published Date: 2024-09-08

    page

    Pages: 190

    USD 4900.00

    (Single User License)

  • Global In Vivo Imaging Systems Market Research Report 2024

    Global In Vivo Imaging Systems Market Research Report 2024

    Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

    selected

    Published Date: 2024-09-08

    page

    Pages: 116

    USD 2900.00

    (Single User License)

  • Global In Vivo Imaging Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

    Global In Vivo Imaging Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

    The global In Vivo Imaging Systems market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 174 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.

    selected

    Published: 2026-01-05

    page

    Pages: 119

    USD 4250.00 (Single User License)
  • Global In Vivo Imaging Systems Market Research Report 2026

    Global In Vivo Imaging Systems Market Research Report 2026

    The global In Vivo Imaging Systems market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 3.1% from 2026 to 2032.

    selected

    Published: 2026-01-05

    page

    Pages: 146

    USD 2900.00 (Single User License)
  • In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

    In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

    The global market for In Vivo Imaging Systems was estimated to be worth US$ 141 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 3.1% from 2026 to 2032.

    selected

    Published: 2026-01-05

    page

    Pages: 165

    USD 3950.00 (Single User License)
  • Global In Vivo Imaging Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

    Global In Vivo Imaging Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

    The global In Vivo Imaging Systems market size was US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.

    selected

    Published: 2025-09-10

    page

    Pages: 116

    USD 4250.00 (Single User License)
  • In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

    In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

    The global market for In Vivo Imaging Systems was estimated to be worth US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.

    selected

    Published: 2025-01-19

    page

    Pages: 157

    USD 3950.00 (Single User License)
  • Global In Vivo Imaging Systems Market Research Report 2025

    Global In Vivo Imaging Systems Market Research Report 2025

    The global market for In Vivo Imaging Systems was valued at US$ 137 million in the year 2024 and is projected to reach a revised size of US$ 169 million by 2031, growing at a CAGR of 3.1% during the forecast period.

    selected

    Published: 2025-01-19

    page

    Pages: 111

    USD 2900.00 (Single User License)
  • Global and United States In Vivo Imaging Systems Market Report & Forecast 2024-2030

    Global and United States In Vivo Imaging Systems Market Report & Forecast 2024-2030

    Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

    selected

    Published: 2024-09-08

    page

    Pages: 174

    USD 4350.00 (Single User License)
  • In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

    In Vivo Imaging Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

    Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

    selected

    Published: 2024-09-08

    page

    Pages: 160

    USD 3950.00 (Single User License)
  • Global In Vivo Imaging Systems Market Insights, Forecast to 2030

    Global In Vivo Imaging Systems Market Insights, Forecast to 2030

    Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

    selected

    Published: 2024-09-08

    page

    Pages: 190

    USD 4900.00 (Single User License)
  • Global In Vivo Imaging Systems Market Research Report 2024

    Global In Vivo Imaging Systems Market Research Report 2024

    Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

    selected

    Published: 2024-09-08

    page

    Pages: 116

    USD 2900.00 (Single User License)
Global In Vivo Imaging Systems Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-07-31

Pages: 184 Pages

Report ld: 4808012

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now